JNCE Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Notice: This stock is marked as potentially delisted. It may not be actively trading.

Insider Ownership Percentage: 6.92%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $0.00

Jounce Therapeutics Insider Trading History Chart

Jounce Therapeutics Share Price & Price History

^$1.88

▼ -0.05 (-2.59%)

As of 05/4/2023 09:00 PM ET

Biden’s $374B Giveaway Into This Sector

From DTI | Ad

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

Click here for the full story

Jounce Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/4/2023	Richard Murray	Director	Sell	39,228	$1.85	$72,571.80	188,779
3/13/2023	Kevin C Tang	Major Shareholder	Buy	65,701	$0.99	$65,043.99	5,279,801
1/9/2023	Elizabeth Trehu	Insider	Sell	4,159	$1.10	$4,574.90	108,543
1/9/2023	Hugh M Cole	COO	Sell	7,452	$1.10	$8,197.20	119,264
1/9/2023	Kimberlee C. Drapkin	CFO	Sell	6,315	$1.10	$6,946.50	73,799
1/9/2023	Richard Murray	CEO	Sell	20,191	$1.10	$22,210.10	252,886
1/10/2022	Elizabeth Trehu	Insider	Sell	5,378	$6.65	$35,763.70
1/10/2022	Kimberlee C. Drapkin	CFO	Sell	8,222	$6.65	$54,676.30
1/10/2022	Richard Murray	CEO	Sell	23,924	$6.65	$159,094.60
1/7/2022	Elizabeth Trehu	Insider	Sell	3,005	$7.30	$21,936.50
1/7/2022	Kimberlee C. Drapkin	CFO	Sell	4,595	$7.30	$33,543.50
1/7/2022	Richard Murray	CEO	Sell	13,370	$7.30	$97,601.00
11/12/2021	Rock Ventures Iii L.P. Third	Major Shareholder	Sell	1,900,000	$8.38	$15,922,000.00
5/25/2021	Rock Ventures Ii L.P. Third	Major Shareholder	Sell	552,520	$8.00	$4,420,160.00

Biden’s $374B Giveaway Into This Sector

From DTI | Ad

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

Click here for the full story

SEC Filings (Institutional Ownership Changes) for Jounce Therapeutics (NASDAQ:JNCE)

80.66% of Jounce Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Jounce Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/18/2023	JPMorgan Chase & Co.	1,136,847	$2.10M	0.0%	+354.4%	2.160%
5/16/2023	Susquehanna International Group LLP	108,297	$0.20M	0.0%	+269.7%	0.206%
5/16/2023	Colony Group LLC	25,000	$46K	0.0%	N/A	0.048%
5/16/2023	Jane Street Group LLC	126,048	$0.23M	0.0%	+603.4%	0.239%
5/16/2023	State Street Corp	807,443	$1.49M	0.0%	+24.5%	1.534%
5/16/2023	Geode Capital Management LLC	767,117	$1.42M	0.0%	+14.4%	1.458%
5/16/2023	Beryl Capital Management LLC	610,831	$1.13M	0.9%	N/A	1.161%
5/15/2023	Two Sigma Advisers LP	47,800	$88K	0.0%	-87.4%	0.091%
5/15/2023	Two Sigma Investments LP	77,200	$0.14M	0.0%	+46.2%	0.147%
5/15/2023	Deutsche Bank AG	452,119	$0.84M	0.0%	+1.7%	0.859%
5/15/2023	XTX Topco Ltd	78,190	$0.15M	0.0%	N/A	0.149%
5/12/2023	Renaissance Technologies LLC	581,300	$1.08M	0.0%	+109.9%	1.105%
5/12/2023	GABELLI & Co INVESTMENT ADVISERS INC.	425,100	$0.79M	0.2%	N/A	0.808%
5/12/2023	Gabelli Funds LLC	526,281	$0.97M	0.0%	N/A	1.000%
5/12/2023	BlackRock Inc.	2,546,289	$4.71M	0.0%	-1.0%	4.838%
5/12/2023	Bank of America Corp DE	37,513	$69K	0.0%	-98.9%	0.071%
5/12/2023	UBS Group AG	21,031	$39K	0.0%	+77.8%	0.040%
5/12/2023	Moloney Securities Asset Management LLC	243,950	$0.45M	0.1%	-49.4%	0.464%
5/12/2023	Dimensional Fund Advisors LP	264,270	$0.49M	0.0%	-63.0%	0.502%
5/12/2023	Panagora Asset Management Inc.	66,554	$0.12M	0.0%	+66.0%	0.126%
5/12/2023	CIBC Private Wealth Group LLC	30,000	$56K	0.0%	-25.8%	0.057%
5/11/2023	Acadian Asset Management LLC	135,324	$0.25M	0.0%	-87.7%	0.257%
5/10/2023	Connor Clark & Lunn Investment Management Ltd.	15,404	$28K	0.0%	N/A	0.029%
5/8/2023	Bailard Inc.	90,200	$0.17M	0.0%	N/A	0.171%
5/4/2023	Barclays PLC	21,498	$39K	0.0%	-43.5%	0.041%
5/1/2023	Virtu Financial LLC	126,209	$0.23M	0.0%	+1,015.4%	0.242%
4/14/2023	BML Capital Management LLC	1,087,961	$2.01M	1.7%	N/A	2.087%
4/12/2023	FNY Investment Advisers LLC	15,000	$27K	0.0%	N/A	0.029%
2/28/2023	Voya Investment Management LLC	155,660	$0.17M	0.0%	+159.7%	0.301%
2/15/2023	Squarepoint Ops LLC	35,606	$40K	0.0%	N/A	0.069%
2/15/2023	Millennium Management LLC	1,828,681	$2.03M	0.0%	N/A	3.538%
2/15/2023	Morgan Stanley	1,657,925	$1.84M	0.0%	-1.2%	3.207%
2/14/2023	Price T Rowe Associates Inc. MD	80,336	$89K	0.0%	+104.2%	0.155%
2/14/2023	Susquehanna International Group LLP	29,292	$33K	0.0%	+824.9%	0.057%
2/14/2023	Two Sigma Investments LP	52,816	$59K	0.0%	-45.5%	0.102%
2/13/2023	Charles Schwab Investment Management Inc.	226,160	$0.25M	0.0%	-6.8%	0.438%
2/13/2023	Deutsche Bank AG	444,720	$0.49M	0.0%	-12.4%	0.860%
2/13/2023	Panagora Asset Management Inc.	40,087	$44K	0.0%	-72.2%	0.078%
2/13/2023	Barclays PLC	38,071	$43K	0.0%	+33.4%	0.074%
2/13/2023	Renaissance Technologies LLC	276,896	$0.31M	0.0%	+247.4%	0.536%
2/13/2023	Geode Capital Management LLC	670,462	$0.74M	0.0%	+2.0%	1.297%
2/13/2023	GSA Capital Partners LLP	44,849	$50K	0.0%	-53.9%	0.087%
2/13/2023	CIBC Private Wealth Group LLC	40,425	$45K	0.0%	+97.9%	0.078%
2/10/2023	Bank of America Corp DE	3,276,699	$3.64M	0.0%	+28,358.4%	6.339%
2/9/2023	Dimensional Fund Advisors LP	715,037	$0.79M	0.0%	-29.0%	1.383%
1/31/2023	Kestra Advisory Services LLC	26,100	$29K	0.0%	-28.2%	0.050%
1/30/2023	Moloney Securities Asset Management LLC	482,450	$0.54M	0.1%	+278.9%	0.933%
1/12/2023	Assenagon Asset Management S.A.	522,578	$0.58M	0.0%	-34.7%	1.011%
12/8/2022	Bank of New York Mellon Corp	144,700	$0.34M	0.0%	+14.5%	0.280%
11/16/2022	Captrust Financial Advisors	35,599	$83K	0.0%	+58.2%	0.069%
11/16/2022	Balyasny Asset Management LLC	11,177	$26K	0.0%	N/A	0.022%
11/16/2022	CIBC Private Wealth Group LLC	20,425	$48K	0.0%	N/A	0.040%
11/16/2022	BNP Paribas Arbitrage SNC	19,876	$47K	0.0%	+118.1%	0.038%
11/15/2022	Jacobs Levy Equity Management Inc.	30,350	$71K	0.0%	-89.1%	0.059%
11/15/2022	Two Sigma Advisers LP	283,800	$0.66M	0.0%	-11.5%	0.549%
11/15/2022	Two Sigma Investments LP	96,974	$0.23M	0.0%	-27.1%	0.188%
11/15/2022	Vanguard Group Inc.	1,625,857	$3.80M	0.0%	+1.4%	3.145%
11/15/2022	PFM Health Sciences LP	4,094,488	$9.58M	0.3%	+3.7%	7.921%
11/15/2022	Price T Rowe Associates Inc. MD	39,336	$93K	0.0%	+100.5%	0.076%
11/15/2022	Bank of New York Mellon Corp	144,700	$0.34M	0.0%	+14.5%	0.280%
11/15/2022	BlackRock Inc.	2,789,315	$6.53M	0.0%	+4.7%	5.396%
11/15/2022	Caxton Associates LP	37,345	$87K	0.0%	N/A	0.072%
11/15/2022	Citadel Advisors LLC	1,455,862	$3.41M	0.0%	-14.1%	2.817%
11/14/2022	RTW Investments LP	5,106,341	$11.95M	0.3%	+17.2%	9.878%
11/14/2022	Renaissance Technologies LLC	79,700	$0.19M	0.0%	-62.2%	0.154%
11/14/2022	Nuveen Asset Management LLC	115,954	$0.27M	0.0%	-26.5%	0.224%
11/14/2022	Healthcare of Ontario Pension Plan Trust Fund	305,200	$0.71M	0.0%	N/A	0.590%
11/10/2022	Connor Clark & Lunn Investment Management Ltd.	144,885	$0.34M	0.0%	+14.9%	0.280%
11/10/2022	Dimensional Fund Advisors LP	1,006,646	$2.36M	0.0%	-15.3%	1.947%
11/8/2022	Congress Asset Management Co. MA	492,556	$1.15M	0.0%	-9.0%	0.953%
11/3/2022	TRV GP II LLC	572,829	$1.34M	100.0%	-57.5%	1.108%
11/3/2022	Barclays PLC	28,543	$66K	0.0%	-89.4%	0.055%
11/1/2022	Kestra Advisory Services LLC	36,350	$85K	0.0%	+38.5%	0.070%
10/31/2022	Moloney Securities Asset Management LLC	127,331	$0.30M	0.1%	-29.1%	0.246%
10/31/2022	Monarch Partners Asset Management LLC	228,370	$0.53M	0.2%	N/A	0.442%
10/27/2022	Assenagon Asset Management S.A.	800,291	$1.87M	0.0%	-41.6%	1.548%
8/19/2022	Walleye Capital LLC	52,427	$0.16M	0.0%	N/A	0.101%
8/18/2022	Goldman Sachs Group Inc.	204,633	$0.62M	0.0%	-47.8%	0.396%
8/16/2022	Price T Rowe Associates Inc. MD	19,618	$59K	0.0%	-69.5%	0.038%
8/15/2022	AQR Capital Management LLC	34,981	$0.11M	0.0%	-61.7%	0.068%
8/15/2022	State Street Corp	657,919	$1.99M	0.0%	+23.9%	1.273%
8/15/2022	Cubist Systematic Strategies LLC	20,975	$64K	0.0%	+67.9%	0.041%
8/15/2022	Point72 Asset Management L.P.	294,731	$0.89M	0.0%	+3.5%	0.570%
8/15/2022	Citadel Advisors LLC	1,694,867	$5.14M	0.0%	+0.6%	3.279%
8/15/2022	Millennium Management LLC	82,739	$0.25M	0.0%	N/A	0.160%
8/13/2022	Renaissance Technologies LLC	211,081	$0.64M	0.0%	+1,066.2%	0.408%
8/13/2022	American International Group Inc.	19,722	$60K	0.0%	+20.5%	0.038%
8/12/2022	Northern Trust Corp	389,280	$1.18M	0.0%	+17.0%	0.753%
8/12/2022	LPL Financial LLC	25,715	$78K	0.0%	-35.2%	0.050%
8/12/2022	FMR LLC	1,265,811	$3.84M	0.0%	+1,083.4%	2.449%
8/12/2022	BNP Paribas Arbitrage SA	9,115	$28K	0.0%	+102.9%	0.018%
8/12/2022	Franklin Resources Inc.	27,598	$84K	0.0%	-29.7%	0.053%
8/12/2022	Rhumbline Advisers	57,441	$0.17M	0.0%	+33.5%	0.111%
8/11/2022	UBS Group AG	26,787	$82K	0.0%	+112.8%	0.052%
8/11/2022	Alps Advisors Inc.	30,656	$93K	0.0%	-42.3%	0.059%
8/11/2022	JPMorgan Chase & Co.	260,570	$0.79M	0.0%	+16.1%	0.504%
8/10/2022	Principal Financial Group Inc.	25,014	$76K	0.0%	+36.1%	0.048%
8/8/2022	Walleye Capital LLC	52,427	$0.16M	0.0%	N/A	0.101%
8/5/2022	Cowen AND Company LLC	2,843,149	$8.62M	0.8%	+395.0%	5.502%
8/5/2022	Connor Clark & Lunn Investment Management Ltd.	126,073	$0.38M	0.0%	-26.3%	0.244%

Data available starting January 2016

Jounce Therapeutics, Inc. is a clinical stage immunotherapy company, which engages in developing treatments for cancer. It also provides novel cancer immunotherapies to attack tumors. The company was founded by Louis M. Weiner, Drew M. Pardoll, Thomas F. Gajewski, James P. Allison, Robert Schreiber, and Padmanee Sharma in 2013 and is headquartered in Cambridge, MA.

Today's Range

Now: $1.88

$1.88

$1.93

50 Day Range

MA: $1.89

$1.84

$1.94

52 Week Range

Now: $1.88

$0.58

$5.87

Volume

11,600,600 shs

Average Volume

2,457,142 shs

Market Capitalization

$98.94 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.75

Who are the company insiders with the largest holdings of Jounce Therapeutics?: Jounce Therapeutics' top insider shareholders include:
Kevin C Tang (Major Shareholder)
Richard /Ca/ Murray (CEO)
Richard /Ca/ Murray (Director)
Hugh M Cole (COO)
Elizabeth Trehu (Insider)
Kimberlee C Drapkin (CFO)
Learn More about top insider investors at Jounce Therapeutics.